» Articles » PMID: 36542174

Autonomic Dysfunction and Cardiovascular Risk in Psoriatic Arthritis

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2022 Dec 21
PMID 36542174
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriatic arthritis (PsA) is an inflammatory disease with a high prevalence of cardiovascular (CV) events due to traditional cardiovascular risk factors and increased systemic inflammation. In this review, our objectives were to (i) evaluate the cardiovascular events and risk factors and (ii) investigate the relationship between autonomic dysfunction and CV diseases in PsA. A systematic review of the literature was done on the Medline/PubMed, Scopus, and the Directory of Open Access Journals databases between January 2017 and July 2022. After screening and exclusions, 73 studies were included for the final review. Patients with PsA have a greater risk of CV diseases and increased traditional CV risk factors, including hypertension, diabetes mellitus, obesity, metabolic syndrome, and dyslipidemia. Although autonomic dysfunction is more common in PsA than in the general population, its relationship with increased CV diseases in these patients is still unclear. Limitations in explaining CV risk in these patient groups complicate patient assessment as cardiovascular risk factors are linked to the morbidity and mortality of PsA, and it is essential to improve an optimal screening and management strategy for CV disease. All CV risk scoring systems cannot fully assess the CV risk in these patients, so in addition to scoring systems, carotid ultrasound evaluation may be a part of the CV evaluation.

Citing Articles

High-quality research on physical therapy in psoriatic arthritis is needed: a systematic review.

Kaerts M, Swinnen T, Dankaerts W, De Vlam K, Neerinckx B Rheumatol Adv Pract. 2024; 8(3):rkae107.

PMID: 39247389 PMC: 11379465. DOI: 10.1093/rap/rkae107.


Cardiovascular manifestations and comorbidities in rheumatic diseases: perspectives on timely diagnosis, prevention, and treatment.

Gasparyan A Clin Rheumatol. 2023; 42(10):2531-2533.

PMID: 37698746 DOI: 10.1007/s10067-023-06762-x.


Editorial: Autonomic nervous system and cardiovascular risk.

Valenti V, Vanderlei L Front Neurosci. 2023; 17:1185320.

PMID: 37081935 PMC: 10111011. DOI: 10.3389/fnins.2023.1185320.

References
1.
Ritchlin C, Colbert R, Gladman D . Psoriatic Arthritis. N Engl J Med. 2017; 376(10):957-970. DOI: 10.1056/NEJMra1505557. View

2.
Husted J, Thavaneswaran A, Chandran V, Gladman D . Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. J Rheumatol. 2013; 40(8):1349-56. DOI: 10.3899/jrheum.121500. View

3.
Polachek A, Touma Z, Anderson M, Eder L . Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies. Arthritis Care Res (Hoboken). 2016; 69(1):67-74. DOI: 10.1002/acr.22926. View

4.
Lauper K, Courvoisier D, Chevallier P, Finckh A, Gabay C . Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2018; 70(12):1756-1763. DOI: 10.1002/acr.23567. View

5.
Provan S, Schafer Olstad D, Solberg E, Smedslund G, Dagfinrud H . Evidence of reduced parasympathetic autonomic regulation in inflammatory joint disease: A meta-analyses study. Semin Arthritis Rheum. 2018; 48(1):134-140. DOI: 10.1016/j.semarthrit.2017.11.010. View